• Facebook
  • Twitter
Cancer World Archive
  • Magazine
HomeGrandroundTargeted drug development by trial or error?

Targeted drug development by trial or error?

Anna Wagstaff

1 September 2006 Grandround 0

Number 14

Download pdf article

Bringing the new wave of targeted cancer drugs to the market poses new challenges for researchers and clinicians. It is not enough to design a smart drug to hit a molecular target. Researchers need to know how to test and develop the drug. The potential prizes are enormous – so is the price of failure.

Download full article

  • cancer research
  • targeted drugs
Previous article
Next article

Related Articles

No Picture
Spotlight on

AACR marks 100 years of researching cancer

Spotlight on 1 August 2007 0
Cover Story

Fatima Cardoso: the next generation

Cover Story 1 November 2005 0
Grandround

Translating good science into new treatments

Grandround 1 May 2008 0

LATEST PRINTED ISSUE

Latest news

  • Four steps to eliminating HPV infections across Europe: an ECCO call for EU action

    News 16 October 2020 0
    A new report underlines that vaccination, screening, treatment and public awareness, provide the cornerstone for eliminating human papillomavirus (HPV) in Europe. The report was published by The European [more]

Facebook

Twitter

Tweet di @CancerworldESO

© Copyright OncoDaily 2018 with all rights reserved - Credits -


Privacy Policy Cookie Policy